Atlantic Union Bankshares’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.4K Hold
200
﹤0.01% 965
2026
Q1
$34.5K Hold
200
﹤0.01% 993
2025
Q4
$39.9K Hold
200
﹤0.01% 955
2025
Q3
$31.3K Buy
+200
New +$31.8K ﹤0.01% 1024

Other funds holding CRL

Atlantic Union Bankshares's CRL Position: Q2 2026 in Review

Atlantic Union Bankshares held its Charles River Laboratories (CRL) position steady in Q2 2026 at 200 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Atlantic Union Bankshares first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Atlantic Union Bankshares held 200 shares of Charles River Laboratories worth $45.4K as of Q2 2026.
  • Atlantic Union Bankshares left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #965 holding.
  • Atlantic Union Bankshares first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.